CDC Model Performance Evaluation Program (MPEP) for Mycobacterium tuberculosis Drug Susceptibility Testing
Attachment 7
M. tuberculosis Results Worksheet
MPEP Mycobacterium tuberculosis Results Worksheet
Public reporting burden of this collection of information is estimated to average 30 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attn: OMB-PRA (0920-0600)
Enter your drug susceptibility test results for each isolate by using the data worksheets below. There are separate worksheets for conventional drug susceptibility results and molecular test results. These worksheets are provided as a tool for recording results prior to online data entry.
Conventional Drug Susceptibility Worksheet: Isolate Method
Drug |
Resistant |
Susceptible |
Borderline |
Contaminated |
No Growth |
Not Done |
Rifampin |
|
|
|
|
|
|
Isoniazid - low level |
|
|
|
|
|
|
Isoniazid - high level |
|
|
|
|
|
|
Ethambutol |
|
|
|
|
|
|
Pyrazinamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
Streptomycin |
|
|
|
|
|
|
Ofloxacin |
|
|
|
|
|
|
Ciprofloxacin |
|
|
|
|
|
|
Moxifloxacin |
|
|
|
|
|
|
Levofloxacin |
|
|
|
|
|
|
Amikacin |
|
|
|
|
|
|
Kanamycin |
|
|
|
|
|
|
Capreomycin |
|
|
|
|
|
|
Ethionamide |
|
|
|
|
|
|
Rifabutin |
|
|
|
|
|
|
Cycloserine |
|
|
|
|
|
|
Para-Amino Salicyclic Acid |
|
|
|
|
|
|
Molecular Results Worksheet: Isolate Method
Drug |
Mutation Detected |
Mutation Not Detected |
No Result |
Not Done |
Rifampin |
|
|
|
|
Isoniazid |
|
|
|
|
Ethambutol |
|
|
|
|
Pyrazinamide |
|
|
|
|
Ofloxacin |
|
|
|
|
Ciprofloxacin |
|
|
|
|
Moxifloxacin |
|
|
|
|
Levofloxacin |
|
|
|
|
Amikacin |
|
|
|
|
Kanamycin |
|
|
|
|
Capreomycin |
|
|
|
|
Ethionamide |
|
|
|
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Yakrus, Mitchell (CDC/OID/NCHHSTP) |
File Modified | 0000-00-00 |
File Created | 2021-01-20 |